Milestone Pharmaceuticals Inc. (MIST)
1.24
+0.02 (1.64%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G Milestone Pharmaceutical Filed by: Pavaki Capital Management LLC
August 7, 2026 1:50 PM - SEC Filing
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
August 4, 2026 4:01 PM - Globe NewsWire
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026 9:30 PM - Globe NewsWire
Alpha Cognition names Dr. Robert Wills as board chairman
June 23, 2026 8:30 AM - StreetInsider
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
June 23, 2026 8:30 AM - BizWire
Form 8-K Milestone Pharmaceutical For: Jun 10
June 15, 2026 4:06 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: Giles Lisa M.
June 12, 2026 4:16 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: Duty Stuart
June 12, 2026 4:16 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: TOMSICEK MICHAEL JOHN
June 12, 2026 4:16 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: Fischer Seth H. Z.
June 12, 2026 4:16 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: Wills Robert James
June 12, 2026 4:16 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: Saik Andrew
June 12, 2026 4:16 PM - SEC Filing
Form 4 Milestone Pharmaceutical For: Jun 10 Filed by: PAPA JOSEPH C
June 12, 2026 4:15 PM - SEC Filing
Form EFFECT Milestone Pharmaceutical
May 26, 2026 6:04 AM - SEC Filing
Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: RTW INVESTMENTS, LP
May 15, 2026 8:26 AM - SEC Filing
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 14, 2026 8:30 AM - Globe NewsWire
Milestone Pharmaceuticals (MIST) PT Lowered to $7 at Wells Fargo
May 14, 2026 6:56 AM - StreetInsider
Form S-3 Milestone Pharmaceutical
May 13, 2026 5:29 PM - SEC Filing
Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: Adage Capital Management, L.P.
May 13, 2026 9:10 AM - SEC Filing
Form 8-K Milestone Pharmaceutical For: May 13
May 13, 2026 7:23 AM - SEC Filing
Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 43c
May 13, 2026 7:17 AM - StreetInsider
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026 7:11 AM - Globe NewsWire
Form 10-Q Milestone Pharmaceutical For: Mar 31
May 13, 2026 7:05 AM - SEC Filing
Full Article List
